163 related articles for article (PubMed ID: 30006303)
1. Host-Derived Serine Protease Inhibitor 6 Provides Granzyme B-Independent Protection of Intestinal Epithelial Cells in Murine Graft-versus-Host Disease.
Mohammadpour H; Du W; O'Neill R; Khalili S; Qiu J; Repasky EA; McCarthy PL; Cao X
Biol Blood Marrow Transplant; 2018 Dec; 24(12):2397-2408. PubMed ID: 30006303
[TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitor 6 protects alloreactive T cells from Granzyme B-mediated mitochondrial damage without affecting graft-versus-tumor effect.
Du W; Mohammadpour H; O'Neill RE; Kumar S; Chen C; Qiu M; Mei L; Qiu J; McCarthy PL; Lee KP; Cao X
Oncoimmunology; 2018; 7(3):e1397247. PubMed ID: 29399396
[TBL] [Abstract][Full Text] [Related]
3. STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function.
Wu Y; Tang CA; Mealer C; Bastian D; Hanief Sofi M; Tian L; Schutt S; Choi HJ; Ticer T; Zhang M; Sui X; Huang L; Mellor AL; Hu CA; Yu XZ
Cell Mol Immunol; 2021 Mar; 18(3):632-643. PubMed ID: 33500563
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
5. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.
Azzi J; Skartsis N; Mounayar M; Magee CN; Batal I; Ting C; Moore R; Riella LV; Ohori S; Abdoli R; Smith B; Fiorina P; Heathcote D; Bakhos T; Ashton-Rickardt PG; Abdi R
J Immunol; 2013 Sep; 191(5):2319-27. PubMed ID: 23913965
[TBL] [Abstract][Full Text] [Related]
6. Granzyme B-mediated damage of CD8+ T cells impairs graft-versus-tumor effect.
Bian G; Ding X; Leigh ND; Tang Y; Capitano ML; Qiu J; McCarthy PL; Liu H; Cao X
J Immunol; 2013 Feb; 190(3):1341-50. PubMed ID: 23264653
[TBL] [Abstract][Full Text] [Related]
7. Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.
Leigh ND; O'Neill RE; Du W; Chen C; Qiu J; Ashwell JD; McCarthy PL; Chen GL; Cao X
J Immunol; 2017 Jul; 199(1):336-347. PubMed ID: 28550198
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells express serine protease inhibitor to evade the host immune response.
El Haddad N; Heathcote D; Moore R; Yang S; Azzi J; Mfarrej B; Atkinson M; Sayegh MH; Lee JS; Ashton-Rickardt PG; Abdi R
Blood; 2011 Jan; 117(4):1176-83. PubMed ID: 21076046
[TBL] [Abstract][Full Text] [Related]
9. Serine protease inhibitor 6 protects iNKT cells from self-inflicted damage.
Ansari AW; Temblay JN; Alyahya SH; Ashton-Rickardt PG
J Immunol; 2010 Jul; 185(2):877-83. PubMed ID: 20543105
[TBL] [Abstract][Full Text] [Related]
10. Serine protease inhibitor-6 differentially affects the survival of effector and memory alloreactive CD8-T cells.
Azzi J; Ohori S; Ting C; Uehara M; Abdoli R; Smith BD; Safa K; Solhjou Z; Lukyanchykov P; Patel J; McGrath M; Abdi R
Am J Transplant; 2015 Jan; 15(1):234-41. PubMed ID: 25534448
[TBL] [Abstract][Full Text] [Related]
11. A new family of 10 murine ovalbumin serpins includes two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (proteinase inhibitor 9).
Sun J; Ooms L; Bird CH; Sutton VR; Trapani JA; Bird PI
J Biol Chem; 1997 Jun; 272(24):15434-41. PubMed ID: 9182575
[TBL] [Abstract][Full Text] [Related]
12. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation.
Graubert TA; DiPersio JF; Russell JH; Ley TJ
J Clin Invest; 1997 Aug; 100(4):904-11. PubMed ID: 9259590
[TBL] [Abstract][Full Text] [Related]
13. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
15. Novel T cell/organoid culture system allows
Matthe DM; Dinkel M; Schmid B; Vogler T; Neurath MF; Poeck H; Neufert C; Büttner-Herold M; Hildner K
Front Immunol; 2023; 14():1253514. PubMed ID: 37705975
[TBL] [Abstract][Full Text] [Related]
16. Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.
Xia G; Truitt RL; Johnson BD
Biol Blood Marrow Transplant; 2006 Apr; 12(4):397-407. PubMed ID: 16545723
[TBL] [Abstract][Full Text] [Related]
17. Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect.
Imado T; Iwasaki T; Kuroiwa T; Sano H; Hara H
Transplantation; 2004 Feb; 77(3):391-8. PubMed ID: 14966413
[TBL] [Abstract][Full Text] [Related]
18. Granzyme B Contributes to the Optimal Graft-Versus-Tumor Effect Mediated by Conventional CD4
Du W; Leigh ND; Bian G; Alqassim E; O'Neill RE; Mei L; Qiu J; Liu H; McCarthy PL; Cao X
J Immunol Res Ther; 2016; 1(1):22-28. PubMed ID: 27774524
[TBL] [Abstract][Full Text] [Related]
19. Spi6 protects alloreactive CD4(+) but not CD8 (+) memory T cell from granzyme B attack by double-negative T regulatory cell.
Su Y; Jevnikar AM; Huang X; Lian D; Zhang Z-
Am J Transplant; 2014 Mar; 14(3):580-93. PubMed ID: 24730048
[TBL] [Abstract][Full Text] [Related]
20. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
